Tc 99m votumumab
Alternative Names: HumaSPECT; VotumumabLatest Information Update: 18 May 2007
At a glance
- Originator Intracel Corporation
- Class Monoclonal antibodies; Monoclonal antibody diagnostics; Radiopharmaceutical diagnostics
- Mechanism of Action Radionuclide imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Market Withdrawal Colorectal cancer
Most Recent Events
- 18 May 2007 Discontinued - Phase-III for Colorectal cancer diagnosis in USA (IV)
- 12 Sep 2003 KS Biomedix Holdings has been acquired by Xenova Group
- 26 Feb 2003 Launched for Colorectal cancer diagnosis in European Union (IV)